• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Valeant Pharmaceuticals International

Valeant Pharmaceuticals International

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. UPDATE: Allergan adopts poison pill in face of Valeant bid

    UPDATE: Allergan adopts poison pill in face of Valeant bid

  2. UPDATE: U.S. stocks rise; Netflix jumps on results

    UPDATE: U.S. stocks rise; Netflix jumps on results

  3. ALLERGAN INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Allergan, Inc.

    ALLERGAN INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Allergan, Inc.

  4. Allergan Pursuer Valeant: A Drug Maker With Little Patience for Science

    Allergan Pursuer Valeant: A Drug Maker With Little Patience for Science

  5. The Deal Announces Candidates For Seventh Annual Most Admired Corporate Dealmakers Awards

    The Deal Announces Candidates For Seventh Annual Most Admired Corporate Dealmakers Awards

  6. Meda and Valeant Terminate Joint Ventures

    Meda and Valeant Terminate Joint Ventures

  7. Our Outlook for the Credit Markets

    Widening investment-grade credit spreads and rising interest rates lead to losses.

  8. How to Tell if Your Fund Invests With Buffett

    Fund portfolio and Berkshire Hathaway shareholder data show which funds hold significant chunks of the company's stock.

1234
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.